Literature DB >> 17364497

Infection and vaccination in chronic fatigue syndrome: myth or reality?

Shmuel Appel1, Joab Chapman, Yehuda Shoenfeld.   

Abstract

Chronic fatigue syndrome (CFS) is characterized by severe disabling fatigue lasting for more than 6 months associated with physical and mental disturbances such as headache, arthralgia, myalgia, memory impairment, sore throat and tender lymph nodes. The exact pathogenesis is still unknown. Several models were proposed to explain its etiology including chronic infection, endocrine dysfunction, autonomic imbalance, depression, decreased immunity states and an aberrant reaction to infection. No convincing evidence was found to support any of the suggested pathogenic mechanisms. The current concept is that CFS pathogenesis is a multi factorial condition in which an infective agent cause an aberrant immune response characterized by a shift to Th-2 dominant response. When the response fails to be switched-off, a chronic immune activation occurs and clinically expressed as the symptomatology of CFS. Vaccinations are used in order to stimulate the immune system to induce a persistent immunity against the favorable antigens. Several syndromes that contain chronic fatigue as one of their symptoms, such as "Gulf war syndrome" and macrophagic myofasciitis were related to vaccinations. Can vaccinations induce the aberrant immune response of CFS? Little is known about this issue. There are some reports on CFS occurring after vaccination, but few prospective and retrospective studies failed to find such an association. A working group of the Canadian Laboratory Center for Disease Control (LCDC) that was founded in order to examine the suspected association between CFS and vaccinations concluded that there is no evidence that relates CFS to vaccination. Further studies are requested to examine this issue since it is very conceivable that if infection can lead to CFS, vaccination may also lead to it in the same immune-mediated pathogenesis.

Entities:  

Mesh:

Year:  2007        PMID: 17364497     DOI: 10.1080/08916930701197273

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  10 in total

1.  Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.

Authors:  Cindy M Chang; Joan L Warren; Eric A Engels
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

2.  Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.

Authors:  Tracy Pondo; Charles E Rose; Stacey W Martin; Wendy A Keitel; Harry L Keyserling; Janiine Babcock; Scott Parker; Robert M Jacobson; Gregory A Poland; Michael M McNeil
Journal:  Vaccine       Date:  2014-04-24       Impact factor: 3.641

3.  Chronic fatigue syndrome defies the mind-body-schism of medicine. New perspectives on a multiple realisable developmental systems disorder.

Authors:  Elling Ulvestad
Journal:  Med Health Care Philos       Date:  2008-02-21

4.  Personality features and personality disorders in chronic fatigue syndrome: a population-based study.

Authors:  Urs M Nater; James F Jones; Jin-Mann S Lin; Elizabeth Maloney; William C Reeves; Christine Heim
Journal:  Psychother Psychosom       Date:  2010-07-28       Impact factor: 17.659

Review 5.  Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions.

Authors:  Nancy G Klimas; Anne O'Brien Koneru
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

6.  Higher Prevalence of "Low T3 Syndrome" in Patients With Chronic Fatigue Syndrome: A Case-Control Study.

Authors:  Begoña Ruiz-Núñez; Rabab Tarasse; Emar F Vogelaar; D A Janneke Dijck-Brouwer; Frits A J Muskiet
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-20       Impact factor: 5.555

Review 7.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

8.  Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.

Authors:  Amos Ben-Zvi; Suzanne D Vernon; Gordon Broderick
Journal:  PLoS Comput Biol       Date:  2009-01-23       Impact factor: 4.475

Review 9.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

10.  Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Oliver P Günther; Jennifer L Gardy; Phillip Stafford; Øystein Fluge; Olav Mella; Patrick Tang; Ruth R Miller; Shoshana M Parker; Stephen A Johnston; David M Patrick
Journal:  Mol Neurobiol       Date:  2018-10-08       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.